Kindred Biosciences Inc (NASDAQ:KIN)

4.57
Delayed Data
As of 3:59pm ET
 -0.21 / -4.39%
Today’s Change
3.11
Today|||52-Week Range
9.83
+6.03%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Kindred Biosciences Inc have a median target of 11.00, with a high estimate of 16.00 and a low estimate of 9.00. The median estimate represents a +140.70% increase from the last price of 4.57.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Kindred Biosciences Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.30
Sales
$926.8K
Reporting Date
Mar 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.52%
 
 
 
 
 
 
Growthannually 67.04%
 
 
 
 
 
 

Sales

Growthquarterly -11.15%
 
 
 
 
 
 
Growthannually 886.37%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.